Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$1.96B |
 |
MedtronicMDT |
-$83M |
 |
Edwards LifesciencesEW |
-$284M |
 |
Intuitive SurgicalISRG |
-$694M |
 |
ConmedCNMD |
-$2.6M |
Are Haemonetics Corporation Insiders Buying or Selling?
Haemonetics Corporation (HAE) has had no reported insider transactions in the past 90 days. The most recent was MARK KROLL, who bought 1,400 shares at $70.56 on November 10, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the HAE AI Score. For government officials trading this stock, see HAE congressional trading.
Recent Haemonetics Corporation Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| MARK KROLL | Nov 10, 2025 | Buy | 1,400 | $70.56 | $99,000 |
Frequently Asked Questions: Haemonetics Corporation Insider Trading
Haemonetics Corporation insiders have not reported any transactions in the past 90 days.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
KROLL MARK W has bought the most HAE stock in the last 2 years, with a total value of $99,000.
According to our estimates, the total value of insider transactions for Haemonetics Corporation in the last 2 years is positive, amounting to $99,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
